Editorial

Home blood glucose monitoring in type 2 diabetes

BMJ 2004; 329 doi: 10.1136/bmj.329.7469.754 (Published 30 September 2004)
Cite this as: BMJ 2004;329:754

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Rebecca M Reynolds, clinical lecturer,
  2. Mark W J Strachan, consultant physician (mark.strachan@luht.scot.nhs.uk)
  1. Endocrinology Unit, School of Molecular and Clinical Medicine, University of Edinburgh, Edinburgh EH4 2XU
  2. Metabolic Unit, Western General Hospital, Edinburgh EH4 2XU

    Regular monitoring is necessary only in some situations

    Diabetes UK, the leading charity for people with diabetes in the United Kingdom, issued the following position statement in July 2003.1 “People with diabetes should have access to home blood glucose monitoring based on individual clinical need, informed consent and not on ability to pay. Home monitoring is essential in the context of diabetes education for self-management in order to enable the person to make appropriate treatment or lifestyle choices.” The first part of this statement is not contentious, and most people would probably agree that people with type 1 or type 2 diabetes treated with insulin should regularly monitor blood glucose, not only to guide insulin doses but also to detect and avoid hypoglycaemia. However, is home blood glucose monitoring necessary for people with type 2 diabetes treated with oral hypoglycaemic agents and dietary modification?

    Home blood glucose monitoring is a big business. The main profit for the …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular